{
  "id": "blood-crossmatching",
  "title": "Blood crossmatching",
  "lang": "en",
  "source_lang": "en",
  "summary": "Blood crossmatching is pretransfusion compatibility testing used to determine whether a particular donor red-cell unit is suitable for a recipient.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Blood cross-matching",
    "Red-cell crossmatching",
    "Pretransfusion crossmatch"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/blood-crossmatching/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/blood-crossmatching/",
      "json": "https://aiwiki.page/zh/blood-crossmatching.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Blood crossmatching is the final compatibility assessment used before most non-emergency red-cell transfusions to determine whether a particular donor unit is suitable for a recipient. It may involve testing the recipient’s plasma or serum against donor red blood cells, or using a validated electronic system to confirm compatibility under defined conditions. Crossmatching forms part of pretransfusion testing alongside blood grouping, antibody screening, and review of previous transfusion records."
    },
    {
      "heading": "Immunological basis",
      "text": "Red blood cells carry inherited surface markers called blood-group antigens. A recipient’s antibodies may recognize donor antigens as foreign and cause cell destruction, or hemolysis. This can produce an acute or delayed hemolytic transfusion reaction.\n\nThe ABO blood group system is particularly important because people generally have antibodies against the A or B antigens they lack. Transfusion of ABO-incompatible red cells can cause rapid, severe intravascular hemolysis.\n\nOther blood-group systems, including Rh, Kell, Kidd, and Duffy, also contain clinically important antigens. Antibodies to these antigens may develop after exposure through transfusion or pregnancy. Their presence can make apparently ABO-compatible donor units unsuitable.\n\nCrossmatching addresses the compatibility of a specific donor unit with a specific recipient. It does not mean that every blood-group antigen in the two individuals is identical."
    },
    {
      "heading": "Relationship to other pretransfusion tests",
      "text": "Several related procedures have distinct purposes:\n\n- ABO and RhD typing determines the recipient’s ABO group and whether the D antigen of the Rh blood group system is present.\n- Antibody screening tests recipient plasma against selected reagent red cells carrying a range of clinically important antigens. It looks for unexpected red-cell antibodies, rather than compatibility with a particular donor unit.\n- Antibody identification investigates a positive screen to determine which antibody or antibodies are present.\n- Crossmatching assesses compatibility with the donor unit selected for transfusion.\n\nA type and screen generally includes blood grouping and antibody screening but does not necessarily mean that specific donor units have been crossmatched or reserved. A negative antibody screen may allow a simpler crossmatching method, provided other eligibility requirements are met."
    },
    {
      "heading": "Principal methods",
      "text": "Immediate-spin crossmatch\n\nIn an immediate-spin crossmatch, recipient plasma or serum is mixed with donor red cells, centrifuged, and examined for agglutination, or visible cell clumping. Its principal purpose is to detect ABO incompatibility.\n\nThis method does not adequately detect all clinically significant antibodies that react at body temperature. Its use as the sole serological crossmatch is therefore generally restricted to recipients with a negative current antibody screen and no history of clinically significant red-cell antibodies, according to applicable laboratory standards.\n\nAntiglobulin crossmatch\n\nAn antiglobulin crossmatch includes incubation and an indirect antiglobulin test to detect antibodies that bind to donor red cells but may not produce visible agglutination on their own. Laboratories may use tube, gel-column, or solid-phase techniques.\n\nThis approach is generally used when a recipient has, or has previously had, a clinically significant red-cell antibody. Donor units are selected to lack the corresponding antigen and are then assessed for compatibility. A historical antibody remains relevant even if its concentration has fallen below the detection threshold of the current screen.\n\nElectronic crossmatch\n\nAn electronic crossmatch uses a validated laboratory information system rather than physically mixing recipient plasma with donor cells. The system checks blood-group information, donor-unit data, antibody-screen results, and eligibility rules before authorizing issue.\n\nElectronic crossmatching is generally restricted to recipients with a negative current antibody screen and no history of clinically significant red-cell antibodies. It also requires safeguards for reliable ABO determination and prevention of incompatible unit selection. Exact requirements differ between jurisdictions and laboratory standards.\n\nIt is not simply an administrative substitution for laboratory testing: its validity depends on the preceding tests, accurate records, and validated software controls."
    },
    {
      "heading": "Specimens and identification",
      "text": "Correct patient and specimen identification are central to patient safety. A technically accurate crossmatch performed on a specimen from the wrong person can still result in an incompatible transfusion.\n\nPretransfusion testing therefore includes checks of specimen labeling, patient identifiers, historical blood-group results, and donor-unit identification. Some systems require an independently collected second sample or an independently established previous blood group before issuing group-specific red cells.\n\nSpecimen validity is time-limited because new antibodies can develop, particularly after recent transfusion or pregnancy. The permitted interval depends on clinical history and local standards. A previously compatible result does not establish indefinite compatibility for future transfusions."
    },
    {
      "heading": "Interpretation and limitations",
      "text": "A compatible serological crossmatch means that no incompatibility was detected using the method and conditions employed. It substantially reduces the risk of immune-mediated red-cell destruction but does not guarantee an uneventful transfusion.\n\nAn incompatible result may reflect an ABO discrepancy, an antibody against a donor antigen, an autoantibody, a technical problem, or interference from certain medicines. Investigation may involve repeat testing, antibody identification, and selection of alternative donor units.\n\nImportant limitations include:\n\n- Antibodies below the method’s detection threshold may not be detected.\n- An antibody that was previously detectable may reappear after transfusion and cause delayed hemolysis.\n- Autoantibodies can react with many donor samples and complicate interpretation.\n- Crossmatching does not assess all causes of transfusion reactions, such as circulatory overload, allergic reactions, or bacterial contamination.\n- Compatibility testing cannot compensate for errors in identifying the patient at the time of administration."
    },
    {
      "heading": "Emergency transfusion and other components",
      "text": "During life-threatening bleeding, red cells may be issued before full compatibility testing is complete. Emergency-release protocols commonly provide group O red cells when the recipient’s ABO group is not yet established, with subsequent selection informed by available testing. Testing continues after emergency release, and detected incompatibilities are communicated through established procedures.\n\nRoutine red-cell crossmatching is generally not performed for plasma or cryoprecipitate, although component-specific compatibility rules still apply. Platelet crossmatching may be used in selected cases of poor platelet response caused by antibodies; it is a distinct procedure.\n\nBlood crossmatching also differs from transplant crossmatching, which principally evaluates recipient antibodies against donor tissue antigens rather than compatibility between donor red cells and recipient plasma."
    }
  ],
  "links": [
    "blood-transfusion",
    "erythrocyte",
    "antibody",
    "hemolysis",
    "abo-blood-group-system",
    "pregnancy",
    "rh-blood-group-system",
    "patient-safety",
    "transplant-crossmatch"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}